Dauntless Investment Group, LLC - Feb 26, 2025 Form SCHEDULE 13G Schedule Report for AEON Biopharma, Inc. (AEON)

Filing Manager: Dauntless Investment Group, LLC
Reporting Manager: Dauntless Investment Group, LLC
Security: AEON Biopharma, Inc. Common
Symbol: AEON
Shares outstanding: 1.12M shares
Disclosed Ownership: 108K shares
Ownership: 9.7%
Form type: SCHEDULE 13G
Date filed: 3/3/2025, 01:51 PM
Date of event: Feb 26, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Dauntless Investment Group, LLC	9.7%	108K	0	0	/s/Matthew Okkerse	CFO